homefeedbacksupportlog on 20-Mar-2010 
  Search
 
   
 
  Top 10s
 Hematology
  Current Top 10 by F1000 Factor
  All Time Top 10 by F1000 Factor
  Most viewed Top 10
(from all journals)
  Most viewed Top 10
(from specialty journals)
  Hidden Jewels

  Sections Covered
Anemias & Hypocellular Marrow Disorders
Bleeding & Coagulation Disorders
Hematologic Transplantation & Transfusion
Hematopoietic Stem Cells
Leukemia & Proliferative Disorders of Hematic Cells
Lymphomas & Myelomas
Non-hematopoietic Stem Cells
Pediatric Hematology
Related Sections
Perioperative Hemostasis & Transfusion Medicine


 ALL TIME TOP 10 BY F1000 FACTOR | Hematology | calculated on 20 March 2010

All Time Top 10 By F1000 Factors are generated every day using papers added to F1000 Medicine since the project started (Top 10s consider papers evaluated in the preceding month). Papers are ranked according to their F1000 Factor which incorporates both the number of times a paper has been evaluated, and the ratings it received. If any papers have an equal F1000 Factor then the most recently added paper is listed first.

 browse faculty | show All Time Top 10 in

to email [Help]


1
Exceptional
F1000 Factor 9.9

Hypothesis
New Finding
 PML targeting eradicates quiescent leukaemia-initiating cells.
Ito K, Bernardi R, …, Teruya-Feldstein J, Pandolfi PP
Nature 2008 Jun 19 453(7198):1072-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Margaret Goodell / Suzanne Watt / Robert Arceci / Paul La Rosée and Michael Deininger
First evaluation 3 Jun 2008 | Latest evaluation 10 Feb 2009
 
2
Exceptional
F1000 Factor 9.8

Hypothesis
New Finding
Tech Advance
 Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.
Raya A, Rodríguez-Pizà I, …, Bueren J, Izpisúa Belmonte JC
Nature 2009 Jul 2 460(7251):53-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Akitsu Hotta and James Ellis / Laura Haneline / Eirini P Papapetrou and Michel Sadelain
First evaluation 15 Jun 2009 | Latest evaluation 7 Sep 2009
 
3
Exceptional
F1000 Factor 9.8
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

New Finding
 Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, …, Silverman LR, International Vidaza High-Risk MDS Survival Study Group
Lancet Oncol 2009 Mar 10(3):223-32 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Elaine Sloand / Mohamad Mohty / Ron Paquette
First evaluation 16 Mar 2009 | Latest evaluation 27 Aug 2009
 
4
Exceptional
F1000 Factor 9.8

New Finding
Tech Advance
Refutation
 Efficient tumour formation by single human melanoma cells.
Quintana E, Shackleton M, …, Johnson TM, Morrison SJ
Nature 2008 Dec 4 456(7222):593-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Ruth Keri / Tura Camilli and Ashani Weeraratna / Angelo Cardoso
First evaluation 2 Jan 2009 | Latest evaluation 3 Jul 2009

 
5
Exceptional
F1000 Factor 9.8

New Finding
 IFNalpha activates dormant haematopoietic stem cells in vivo.
Essers MA, Offner S, …, Duchosal MA, Trumpp A
Nature 2009 Feb 11 [abstract on PubMed] [related articles] [full text]
Selected by | Mark Berneburg / Ulf Mueller-Ladner / Paul La Rosée and Michael Deininger
First evaluation 27 Feb 2009 | Latest evaluation 19 Mar 2009

 
6
Exceptional
F1000 Factor 9.6

New Finding
 Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
Colmone A, Amorim M, …, Jablonski E, Sipkins DA
Science 2008 Dec 19 322(5909):1861-5 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Vaskar Saha / Toyosi Odenike and Richard Larson
First evaluation 9 Feb 2009 | Latest evaluation 24 Feb 2009
 
7
Exceptional
F1000 Factor 9.6

New Finding
 Programmed anuclear cell death delimits platelet life span.
Mason KD, Carpinelli MR, …, Huang DC, Kile BT
Cell 2007 Mar 23 128(6):1173-86 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Neil Kaplowitz / Chris Prowse
First evaluation 23 Apr 2007 | Latest evaluation 20 Jun 2007

 
8
Exceptional
F1000 Factor 9.0

New Finding
 Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia.
Rosti G, Palandri F, …, Saglio G, Baccarani M
Blood 2009 Oct 12 [abstract on PubMed] [related articles] [full text]
Selected by | Ronan Swords and Francis Giles
Evaluated 13 Nov 2009
 
9
Exceptional
F1000 Factor 9.0

New Finding
Tech Advance
 Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome.
Shu X, Royant A, …, Steinbach PA, Tsien RY
Science 2009 May 8 324(5928):804-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Catriona Jamieson
Evaluated 23 Jul 2009

 
10
Exceptional
F1000 Factor 9.0

Confirmation
New Finding
 The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.
Minelli A, Maserati E, …, Pasquali F, Danesino C
Leukemia 2009 Jan 15 [abstract on PubMed] [related articles] [full text]
Selected by | Philip Mason and David Wilson and Monica Bessler
Evaluated 30 Jan 2009

© 2010 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info